Home › Companies › Repare Therapeutics Inc.

Repare Therapeutics Inc. proxy voting records

How asset managers voted at Repare Therapeutics Inc.’s shareholder meetings, one page per proxy season, compiled from the votes funds and managers report on SEC Form N-PX and the company’s own results on Form 8-K.

• CUSIP issuer number760273
• SEC CIK1808158

Recent shareholder votes

• June 17, 2024 annual meeting (2023-2024 proxy season): 4 items in Repare Therapeutics Inc.'s official results (Form 8-K, filed June 17, 2024); lowest support 98% of votes cast (Elect Director: Ann D. Rhoads). Full results and how funds voted.

Each line is the company’s own Form 8-K tally as shown on that season’s page; support is FOR as a share of votes cast.

Proxy seasons

Earlier seasons list this company under the name REPARE THERAPEUTICS INC., as its holders filed it.

Explore Repare Therapeutics Inc. in the interactive database

The seasons are grouped by the issuer number in the company’s CUSIP, not by its name. This page is rebuilt weekly; built November 9, 2026.